BrainsWay Q2 Revenue Jumps 35% to Record $17.1M, Raises Full-Year Guidance
BWAY has more than doubled off its 52-week low of $5.885.
Summary
BrainsWay reported record Q2 2026 revenue of $17.1 million, up 35% year-over-year, with Adjusted EBITDA more than doubling to $3.5 million. The company raised its full-year revenue and EBITDA guidance, citing strong system shipments and growing insurer coverage.
Key Events · Earnings and Guidance · BWAY
-
Record Q2 Revenue and Profitability
Revenue grew 35% YoY to $17.1M; Adjusted EBITDA more than doubled to $3.5M (20% margin); operating income surged over 300% to $2.4M.
-
Raised Full-Year Guidance
FY2026 revenue guidance raised to $68M-$70M (from $66M-$68M), implying ~30-34% growth; Adjusted EBITDA guidance raised to $13M-$14M (from $12M-$14M), implying ~90-100% growth.
-
Strong Demand Indicators
Record 125 Deep TMS systems shipped (42% YoY increase); remaining performance obligations (RPO) rose 30% YoY to $80.4M, providing revenue visibility.
-
Cash Generation and Balance Sheet
Generated $6.3M in operating cash flow in Q2; cash and equivalents totaled $62.4M as of June 30, 2026, up 6% sequentially.
Analysis · BWAY · Industrial Applications And Services
BrainsWay delivered its second consecutive quarter of ~35% revenue growth, with Q2 revenue hitting a record $17.1 million. Adjusted EBITDA more than doubled to $3.5 million, and the company generated $6.3 million in operating cash flow. Record system shipments and a 30% jump in remaining performance obligations to $80.4 million signal strong demand momentum. Management raised full-year revenue and EBITDA guidance, reflecting confidence in continued expansion driven by growing reimbursement coverage and higher utilization. The results reinforce the commercial traction of the Deep TMS platform and the SWIFT accelerated protocol.
At the time of this filing, BWAY was trading at $15.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $603.6M. The 52-week trading range was $5.89 to $17.35. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.